Sitanshu S. Singh

788 total citations
26 papers, 585 citations indexed

About

Sitanshu S. Singh is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sitanshu S. Singh has authored 26 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sitanshu S. Singh's work include Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (6 papers) and Chemical Synthesis and Analysis (4 papers). Sitanshu S. Singh is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), HER2/EGFR in Cancer Research (6 papers) and Chemical Synthesis and Analysis (4 papers). Sitanshu S. Singh collaborates with scholars based in United States, Egypt and India. Sitanshu S. Singh's co-authors include Seetharama D. Jois, Achyut Dahal, Rushikesh Sable, M. Graça H. Vicente, Konstantin G. Kousoulas, Nektarios Barabutis, Ted J. Gauthier, Abu Bakar Siddique, Khalid A. El Sayed and Andrew V. Schally and has published in prestigious journals such as Journal of Controlled Release, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Sitanshu S. Singh

26 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sitanshu S. Singh United States 13 290 127 109 102 74 26 585
Jingbo Yang China 15 310 1.1× 101 0.8× 126 1.2× 70 0.7× 80 1.1× 28 605
Xiaocen Li China 14 507 1.7× 139 1.1× 138 1.3× 107 1.0× 65 0.9× 38 853
Xiaoyong Dai China 15 350 1.2× 99 0.8× 49 0.4× 116 1.1× 70 0.9× 56 620
Xingchen Liu China 17 342 1.2× 77 0.6× 74 0.7× 127 1.2× 83 1.1× 67 838
Gopal Pathuri United States 12 198 0.7× 55 0.4× 80 0.7× 91 0.9× 74 1.0× 44 487
Funmilola A. Fisusi Nigeria 6 196 0.7× 129 1.0× 154 1.4× 113 1.1× 65 0.9× 10 499
Babita Shashni Japan 13 149 0.5× 128 1.0× 66 0.6× 56 0.5× 73 1.0× 22 443
Vanminh Le China 14 226 0.8× 159 1.3× 112 1.0× 116 1.1× 93 1.3× 17 583
Hongyu Qiao China 13 292 1.0× 201 1.6× 109 1.0× 50 0.5× 92 1.2× 23 757

Countries citing papers authored by Sitanshu S. Singh

Since Specialization
Citations

This map shows the geographic impact of Sitanshu S. Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sitanshu S. Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sitanshu S. Singh more than expected).

Fields of papers citing papers by Sitanshu S. Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sitanshu S. Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sitanshu S. Singh. The network helps show where Sitanshu S. Singh may publish in the future.

Co-authorship network of co-authors of Sitanshu S. Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Sitanshu S. Singh. A scholar is included among the top collaborators of Sitanshu S. Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sitanshu S. Singh. Sitanshu S. Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Sitanshu S., et al.. (2023). Experimental investigation of micro-machining on borosilicate glass using mist flow aided WECDM. Proceedings of the Institution of Mechanical Engineers Part E Journal of Process Mechanical Engineering. 238(6). 2782–2796. 1 indexed citations
2.
Dahal, Achyut, et al.. (2022). 1,3‐diarylpyrazolones as potential anticancer agents for non‐small cell lung cancer: Synthesis and antiproliferative activity evaluation. Chemical Biology & Drug Design. 99(4). 620–633. 7 indexed citations
3.
Dahal, Achyut, et al.. (2022). Targeting protein–protein interaction for immunomodulation: A sunflower trypsin inhibitor analog peptidomimetic suppresses RA progression in CIA model. Journal of Pharmacological Sciences. 149(3). 124–138. 2 indexed citations
4.
Dahal, Achyut, Sitanshu S. Singh, Samy M. Ibrahim, et al.. (2021). Quinazoline‐tethered hydrazone: A versatile scaffold toward dual anti‐TB and EGFR inhibition activities in NSCLC. Archiv der Pharmazie. 354(12). e2100281–e2100281. 10 indexed citations
5.
Singh, Sitanshu S., George Mattheolabakis, Xin Gu, et al.. (2021). A grafted peptidomimetic for EGFR heterodimerization inhibition: Implications in NSCLC models. European Journal of Medicinal Chemistry. 216. 113312–113312. 14 indexed citations
6.
Singh, Sitanshu S., et al.. (2021). Mini-Review: PDPK1 (3-phosphoinositide dependent protein kinase-1), An Emerging Cancer Stem Cell Target. PubMed. 5(1). 30–35. 5 indexed citations
7.
Zhou, Zehua, et al.. (2021). Click Conjugation of Boron Dipyrromethene (BODIPY) Fluorophores to EGFR-Targeting Linear and Cyclic Peptides. Molecules. 26(3). 593–593. 6 indexed citations
8.
Dahal, Achyut, Sitanshu S. Singh, Xin Gu, et al.. (2021). A pH-sensitive liposome formulation of a peptidomimetic-Dox conjugate for targeting HER2 + cancer. International Journal of Pharmaceutics. 612. 121364–121364. 28 indexed citations
9.
Zhou, Zehua, et al.. (2020). Targeting EGFR Overexpression at the Surface of Colorectal Cancer Cells by Exploiting Amidated BODIPY‐Peptide Conjugates. Photochemistry and Photobiology. 96(3). 581–595. 8 indexed citations
10.
Singh, Sitanshu S., Achyut Dahal, George Mattheolabakis, et al.. (2020). In vivo studies of a peptidomimetic that targets EGFR dimerization in NSCLC. Journal of Cancer. 11(20). 5982–5999. 4 indexed citations
11.
Siddique, Abu Bakar, Sitanshu S. Singh, Sharon A. Meyer, et al.. (2020). (−)-Oleocanthal as a Dual c-MET-COX2 Inhibitor for the Control of Lung Cancer. Nutrients. 12(6). 1749–1749. 28 indexed citations
12.
Dahal, Achyut, et al.. (2020). Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment. Journal of Controlled Release. 329. 624–644. 111 indexed citations
13.
Singh, Sitanshu S., et al.. (2019). Genotype Driven Therapy for Non-Small Cell Lung Cancer: Resistance, Pan Inhibitors and Immunotherapy. Current Medicinal Chemistry. 27(32). 5274–5316. 33 indexed citations
14.
Chamcheu, Jean Christopher, Stéphane Esnault, Vaqar M. Adhami, et al.. (2019). Fisetin, a 3,7,3′,4′-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models. Cells. 8(9). 1089–1089. 64 indexed citations
15.
Singh, Sitanshu S., et al.. (2018). Design of cyclic and d‐amino acids containing peptidomimetics for inhibition of protein‐protein interactions of HER2‐HER3. Journal of Peptide Science. 24(2). 11 indexed citations
16.
Gauthier, Ted J., et al.. (2018). Design of novel lipidated peptidomimetic conjugates for targeting EGFR heterodimerization in HER2 + cancer. Bioorganic & Medicinal Chemistry Letters. 28(22). 3506–3513. 6 indexed citations
17.
Sable, Rushikesh, et al.. (2017). Peptide ligands for targeting the extracellular domain of EGFR: Comparison between linear and cyclic peptides. Chemical Biology & Drug Design. 91(2). 605–619. 25 indexed citations
18.
Singh, Sitanshu S. & Seetharama D. Jois. (2017). Homo- and Heterodimerization of Proteins in Cell Signaling: Inhibition and Drug Design. Advances in protein chemistry and structural biology. 111. 1–59. 18 indexed citations
19.
Liu, Yu, et al.. (2017). A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerization. Oncotarget. 8(43). 74244–74262. 12 indexed citations
20.
Singh, Sitanshu S.. (2011). In Situ Gelling Ophthalmic Drug Delivery System For Glaucoma. International Journal of Pharma and Bio Sciences. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingbo Yang Breakdown of academic impact, for papers by Xiaocen Li Breakdown of academic impact, for papers by Xiaoyong Dai Breakdown of academic impact, for papers by Xingchen Liu Breakdown of academic impact, for papers by Gopal Pathuri Breakdown of academic impact, for papers by Funmilola A. Fisusi Breakdown of academic impact, for papers by Babita Shashni Breakdown of academic impact, for papers by Vanminh Le Breakdown of academic impact, for papers by Hongyu Qiao
Rankless by CCL
2026